warningSome of our site features may not be supported below Internet Explorer 8. For the best experience, please upgrade to a current browser. close

← return to main site

In Focus
The M&S Technologies blog

Carolyn Crabb

Marketing Coordinator

So Many Firsts: Patricia Bath, MD

Patricia Bath was born in Harlem in 1942. Her father, Rupert Bath, was an immigrant from the island of Trinidad. Her mother, Gladys Bath, was an American citizen, whose direct descendants were African slaves and Cherokee Indians. Patricia’s father was a community activist and a columnist for the Harlem-based, African American owned Amsterdam News, and her mother worked as a domestic. “Although we did not have much, by their…

Click here to read more

Carolyn Crabb

Marketing Coordinator

And the Award Goes To…

Our Glare Testing System was recently patented by the US Patent Office, #8,550,631! Kevin Butler, our Director of Technology, is now in the company of other patented inventors like Christopher Sholes (Typewriter), Henry Phillips (Phillips screw), and William Seward Burroughs (Calculator). But just who was granted Patent #0,000,0001?

The word patent comes from the Latin ‘litterae patentes’, meaning an open letter. Such letters were…

Click here to read more

Carolyn Crabb

Marketing Coordinator

Resisting Technology

Today’s blog post comes from Joe Marino, President of M&S. Joe recently presented at the annual meeting of the Association of Schools and Colleges of Optometry (ASCO) in St. Louis, along with other industry leaders in technology, about the importance of embracing the technological advances available to today’s eyecare professional.


There is a problem that exists within eye care and it deals with a lack of…

Click here to read more

Carolyn Crabb

Marketing Coordinator

Breakthrough Findings

A research team, led by John Guy, M.D., professor of ophthalmology at Bascom Palmer Eye Institute, has pioneered a novel technological treatment for Leber Hereditary Optic Neuropathy (LHON), an inherited genetic defect that causes rapid, permanent, and bilateral loss of vision in people of all ages, but primarily males ages 20-40. Genetic mutations in the mitochondria (part of the cell that produces energy) cause the disorder. Currently, there is no cure for LHON.



Click here to read more

 1 2 > 

Since 1990, M&S® Technologies has served eye care professionals.
We invite you to Find it in Smart System®!

Covered by US Patents: 7,354,155; 7,926,948; 8,425,040; 8,167,429; 8,419,184; 8,550,631 and other patents pending.